<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: MHRA advice on rimonabant</title>
	<atom:link href="http://www.prescriber.org.uk/2007/07/20/mhra-advice-on-rimonabant/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.prescriber.org.uk/2007/07/20/mhra-advice-on-rimonabant/</link>
	<description>An NHS Prescribing Advisers' Blog</description>
	<pubDate>Mon, 13 Oct 2008 15:41:21 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Prescribing Advice for GPs &#187; MeReC Extra 32</title>
		<link>http://www.prescriber.org.uk/2007/07/20/mhra-advice-on-rimonabant/#comment-2593</link>
		<dc:creator>Prescribing Advice for GPs &#187; MeReC Extra 32</dc:creator>
		<pubDate>Mon, 31 Mar 2008 09:16:51 +0000</pubDate>
		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=401#comment-2593</guid>
		<description>[...] risk of adverse events and also serious adverse events with rimonabant compared to placebo. Recent advice has indicated that this drug must not be used in patients who are taking antidepressants and who [...]</description>
		<content:encoded><![CDATA[<p>[...] risk of adverse events and also serious adverse events with rimonabant compared to placebo. Recent advice has indicated that this drug must not be used in patients who are taking antidepressants and who [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
